| human | Q5 |
| P496 | ORCID iD | 0000-0003-1708-272X |
| P108 | employer | Sapienza University of Rome | Q209344 |
| P735 | given name | Francesco | Q2268455 |
| Francesco | Q2268455 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q43812794 | Current ways of treating dyslipidemias to prevent atherosclerosis. |
| Q26776043 | Does Lysosomial Acid Lipase Reduction Play a Role in Adult Non-Alcoholic Fatty Liver Disease? |
| Q39707817 | Effects of dark chocolate on NOX-2-generated oxidative stress in patients with non-alcoholic steatohepatitis. |
| Q104560018 | HDL-Mediated Cholesterol Efflux and Plasma Loading Capacities Are Altered in Subjects with Metabolically- but Not Genetically Driven Non-Alcoholic Fatty Liver Disease (NAFLD) |
| Q92491833 | Lysosomal acid lipase activity and liver fibrosis in the clinical continuum of non-alcoholic fatty liver disease |
| Q37556294 | Moderate weight loss decreases oxidative stress and increases antioxidant status in patients with metabolic syndrome |
| Q33886923 | Modern approach to the clinical management of non-alcoholic fatty liver disease |
| Q33583595 | NOX2-generated oxidative stress is associated with severity of ultrasound liver steatosis in patients with non-alcoholic fatty liver disease |
| Q99414159 | New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress |
| Q42209709 | Non-alcoholic fatty liver disease, metabolic syndrome and patatin-like phospholipase domain-containing protein3 gene variants. |
| Q58420842 | Obesity and Hypercholesterolemia are Associated with NOX2 Generated Oxidative Stress and Arterial Dysfunction |
| Q34348192 | Oxidative stress mediated arterial dysfunction in patients with obstructive sleep apnoea and the effect of continuous positive airway pressure treatment |
| Q28084150 | Oxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosis |
| Q47139049 | PNPLA3 variant and portal/periportal histological pattern in patients with biopsy-proven non-alcoholic fatty liver disease: a possible role for oxidative stress |
| Q35947534 | Reduced Lysosomal Acid Lipase Activity in Adult Patients With Non-alcoholic Fatty Liver Disease |
| Q41209308 | Relation of nonalcoholic fatty liver disease and Framingham Risk Score to flow-mediated dilation in patients with cardiometabolic risk factors |
| Q58575342 | Remnant Lipoprotein Cholesterol and Cardiovascular and Cerebrovascular Events in Patients with Non-Alcoholic Fatty Liver Disease |
| Q37616138 | Serum Cytokeratin-18 Is Associated with NOX2-Generated Oxidative Stress in Patients with Nonalcoholic Fatty Liver |
| Q38843749 | Severe reduction of blood lysosomal acid lipase activity in cryptogenic cirrhosis: A nationwide multicentre cohort study |
| Q36751392 | Similar Reduction of Cholesterol-Adjusted Vitamin E Serum Levels in Simple Steatosis and Non-Alcoholic Steatohepatitis |
| Q40049884 | Spleen dimensions are inversely associated with lysosomal acid lipase activity in patients with non-alcoholic fatty liver disease. |
| Q91970182 | Statins and non-alcoholic fatty liver disease |
| Q27002905 | The efficacy and safety of statins for the treatment of non-alcoholic fatty liver disease |
Search more.